1. Chronic airflow obstruction and ambient particulate air pollution
- Author
-
Hamid Hacene Cherkaski, Rain Jõgi, Peter Burney, Eric D. Bateman, Terence A. R. Seemungal, Rune Nielsen, Gregory E. Erhabor, Filip Mejza, Padukudru Anand Mahesh, David M. Mannino, Asaad Ahmed Nafees, Amund Gulsvik, Guy B. Marks, Cosetta Minelli, Louisa Gnatiuc, Cristina Bárbara, Thorarinn Gislason, Mohammed Al Ghobain, Althea Aquart-Stewart, Meriam Denguezli, Ali Kocabas, Tobias Welte, Christer Janson, Kevin Mortimer, Herve Lawin, Andre F.S. Amaral, Emiel F.M. Wouters, Imed Harrabi, A. Sonia Buist, Jaymini Patel, O.F. Awopeju, Michael Studnicka, Talant Sooronbaev, Li Cher Lo, Daniel O. Obaseki, Elaine Fuertes, Sanjay Juvekar, Bertrand Hugo Mbatchou Ngahane, Asma El Sony, Parvaiz A Koul, Wan C. Tan, RS: NUTRIM - R3 - Respiratory & Age-related Health, Pulmonologie, MUMC+: MA Longziekten (3), Repositório da Universidade de Lisboa, Group, The BOLD (Burden of Obstructive Lung Disease) Collaborative Research, and Wellcome Trust
- Subjects
Pulmonary and Respiratory Medicine ,wa_754 ,Male ,Passive smoking ,Respiratory Medicine and Allergy ,Respiratory System ,wa_750a ,010501 environmental sciences ,Airflow obstruction ,medicine.disease_cause ,Brief Communication ,01 natural sciences ,03 medical and health sciences ,Arbetsmedicin och miljömedicin ,Pulmonary Disease, Chronic Obstructive ,0302 clinical medicine ,Environmental health ,BOLD (Burden of Obstructive Lung Disease) Collaborative Research Group members ,Air Pollution ,Medicine ,Humans ,0105 earth and related environmental sciences ,Lungmedicin och allergi ,Air Pollutants ,Science & Technology ,Poverty ,business.industry ,Tobacco control ,1103 Clinical Sciences ,Dust ,Occupational Health and Environmental Health ,Environmental Exposure ,Particulates ,Particulate air pollution ,medicine.disease ,Obstructive lung disease ,BOLD (Burden of Obstructive Lung Disease) Collaborative Research Group ,PREVALENCE ,Gross national income ,030228 respiratory system ,wf_140 ,Female ,Particulate Matter ,business ,COPD epidemiology ,Life Sciences & Biomedicine ,wf_600 - Abstract
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/., Smoking is the most well-established cause of chronic airflow obstruction (CAO) but particulate air pollution and poverty have also been implicated. We regressed sex-specific prevalence of CAO from 41 Burden of Obstructive Lung Disease study sites against smoking prevalence from the same study, the gross national income per capita and the local annual mean level of ambient particulate matter (PM2.5) using negative binomial regression. The prevalence of CAO was not independently associated with PM2.5 but was strongly associated with smoking and was also associated with poverty. Strengthening tobacco control and improved understanding of the link between CAO and poverty should be prioritised., Supported by Wellcome Trust grant 085790/Z/08/Z for the BOLD (Burden of Obstructive Lung Disease) Study. The initial BOLD programprogramme was funded in part by unrestricted educational grants to the Operations CenterCentre in Portland, Oregon from Altana, Aventis, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Merck, Novartis, Pfizer, Schering-Plough, Sepracor, and the University of Kentucky (Lexington, KY). A full list of local funders can be found at https://www.boldstudy.org.
- Published
- 2021